{
    "2021-05-23": [
        [
            {
                "time": "",
                "original_text": "医药主题公募坚守核心资产 差异化选股能力成为业绩分水岭",
                "features": {
                    "keywords": [
                        "医药",
                        "公募基金",
                        "核心资产",
                        "差异化选股",
                        "业绩分水岭"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}